Gemita – Gemcitabine Injection
GEMCITABINE (GEMITA) INJECTION – TREATMENT FOR MULTIPLE CANCER
Non-small cell lung cancer, breast cancer, pancreatic cancer, urinary bladder cancer, and ovarian cancer are all treated with Gemita injection.
A licensed physician administers Gemita Injection intravenously. Your doctor will determine the appropriate dosage and frequency of administration for you. This is based on the condition you are being treated for and is subject to change.
Fedelty Health Care is a Gemcitabine wholesaler, Pharmaceutical Cargo Bulk Exporter & Hospital Supply.
USES OF GEMCITABINE (GEMITA) INJECTION
- Non-small cell lung cancer
- Breast cancer
- Pancreatic cancer
- Urinary bladder cancer
- Ovarian cancer
WORKS OF GEMCITABINE (GEMITA) INJECTION
By swapping their building elements, Gemita Injection prevents cancer cells’ DNA and RNA from growing. It stops the growth and reproduction of cancer cells.
SIDE EFFECTS OF GEMCITABINE (GEMITA) INJECTION
- Loss of appetite
- Hair loss
- Low blood platelets
- Allergic reaction
- Decreased white blood cell count
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Flu-like symptoms
- Blood in urine
- Skin rash
- Protein in urine
WARNING & PRECAUTIONS
Gemita Injection may make you feel drowsy and lightheaded, less alert, or have an effect on your vision. If you experience these symptoms, don’t drive.
Gemita Injection should not be used during pregnancy because there is clear evidence that it poses harm to the unborn child. However, if the advantages outweigh the possible risks, a doctor might very rarely recommend it in specific life-threatening circumstances. Please speak with your physician.
Fedelty Health Care is a Gemcitabine third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.